CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00497705
NCT00497705N/ACompleted

Genes Causing Congenital Ebstein's Anomaly

National Heart, Lung, and Blood Institute (NHLBI)·observational·Posted Jul 9, 2007·Updated Jul 2, 2017

In Brief

An observational study for Heart Septal Defects, Ventricle and 3 related conditions. Completed, across 3 sites in 3 countries.

Detailed Summary

This study will investigate Ebstein's anomaly, a congenital abnormality of the tricuspid valve of the heart and try to identify the genetic origins of the disease. Adults and children 2 years of age and older with Ebstein's anomaly and healthy volunteers may be eligible for this study. Participants undergo the following procedures: * Blood tests: Three tube of blood will be collected, with the total amount limited to about half a teaspon for each two pounds of body weight. * Saliva sample collection: A small amount of saliva is collected by spitting into a sterile container. * Oral (cheek) swab: Cells are collected from the mouth using a soft brush to swab the inside lining of the cheek. * Electrocardiogram: The electrical activity of the heart is recorded using electrodes placed on the chest. * Echocardiogram: Heart function is assessed using ultrasound.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesBelarus, Ukraine, United States
Collaborators--

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 9, 2007
Enrollment StartJul 3, 2007
Primary CompletionJul 7, 2009
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 19.0 years ago